Advantage Alpha Capital Partners LP Catalent, Inc. Transaction History

Advantage Alpha Capital Partners LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $4.97 Million - $5.78 Million	-41,591 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$109.17 - $142.35 $556,767 - $725,985	-5,100 Reduced 10.92%	41,591 $5.54 Million
Q2 2021 Aug 16, 2021	BUY	$100.34 - $115.69 $713,517 - $822,671	7,111 Added 17.97%	46,691 $5.05 Million
Q1 2021 May 13, 2021	SELL	$101.51 - $125.27 $3.29 Million - $4.07 Million	-32,456 Reduced 45.06%	39,580 $4.17 Million
Q4 2020 Feb 16, 2021	BUY	$85.88 - $105.36 $3.23 Million - $3.97 Million	37,641 Added 109.44%	72,036 $7.5 Million
Q3 2020 Nov 16, 2020	SELL	$72.74 - $92.5 $2.71 Million - $3.45 Million	-37,310 Reduced 52.03%	34,395 $2.95 Million
Q2 2020 Aug 13, 2020	SELL	$48.02 - $79.04 $1.14 Million - $1.88 Million	-23,751 Reduced 24.88%	71,705 $5.26 Million
Q1 2020 May 15, 2020	BUY	$36.95 - $62.95 $329,557 - $561,451	8,919 Added 10.31%	95,456 $4.96 Million
Q4 2019 Feb 14, 2020	BUY	$47.06 - $56.64 $4.07 Million - $4.9 Million	86,537 New	86,537 $4.87 Million

469

148M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Advantage Alpha Capital Partners LP, based on Form 13F filings with the SEC.

Stay updated on Advantage Alpha Capital Partners LP with notifications on news.